CORPORATE BRANDING, COMMUNICATION
AND TRUST - HOW DOES YOUR PHARMA COMPANY MEASURE UP?
Corporate
Branding Overview
Cut throat. It’s the only way to describe the pharmaceutical
marketplace right now with extraordinary levels of competition
threatening companies around the globe!
In order for pharma companies
to succeed in this competitive marketplace they need to implement
superior corporate branding initiatives. The pharmaceutical
industry is under increasing pressure as every activity continues
to undergo microscopic inspection. And as corporate reputation
and image is closely aligned with trust in the minds of consumers
its never been more important for big pharma to be conscious
about the strength and value of its corporate brand. Corporate
branding is the best way to improve both investor and stakeholder
relations. It is also imperative that your corporate branding
strategy is reviewed in order to make sure it can work on
a closer level with product branding strategy. Ensuring a
strong relationship between these two functions will result
in increased company image, a stronger global corporate brand
and a bolstering bottom line!
Your competitors are already
launching major corporate branding campaigns to differentiate
themselves and gain a competitive advantage over you…Isn’t
it time YOU did the same?
eyeforpharma’s premier
event on Corporate Branding, Reputation and Trust will tackle
the HOTTEST issues challenging your company both now and in
the future! In just 2 fact filled days you will learn from
key industry leaders the major gains of implementing a corporate
branding and communications strategy leaving you fully equipped
with an action plan of changes you can implement to increase
your bottom line and company profile immediately!
With the participation of…….
Novartis
Novo Nordisk
Bayer
Lilly
Interbrand
NHS
And many more leading pharma
companies still to be confirmed….
Click
here for a full list of speakers’ job titles and
companies. If you would like to know the names of the speakers
email snawaz@eyeforpharma
for a full list and a pdf of the flyer.
Topics will include:
What is the value of a corporate brand?
How can you use corporate image, brand management, reputation
and trust as strategic tools to maintain long term financial
success?
Corporate branding, reputation and communication on a cross
industry platform – What can the pharma industry learn
from these companies?
What is the relationship between corporate branding and
product branding? How can you better align these two functions
to work together?
What impact will a strong corporate brand have on the lifecycle
of your drugs once they have come off patent?
How can corporate branding and communication help the pharma
industry deliver a clear, concise and consistent message to
all stakeholders?
How have corporate mergers and acquisitions impacted corporate
identity and communications?
What are the principle advantages of having an ongoing corporate
brand rather than a one time corporate brand exercise?
How do you effectively launch a corporate brand campaign
that is both trusted and legal?
Learn how you can measure results achieved through corporate
branding?
How do you get CEO’s to believe that corporate branding
is more than just a logo?
Click
here for full provisional conference programme.
Click
here for updates
Target Audience:
Attendees will be senior level pharma executives from corporate
affairs, corporate communications, marketing, public relations
and investor relations departments. Click
here to be reminded about the event
Conference Structure:
The conference will be two days of in-depth speeches and panel
sessions on how pharmaceutical companies can invest in corporate
branding, communications, reputation and trust to significantly
boost their bottom line. Speakers will largely be from within
the pharmaceutical industry and will include leading executives
from corporate branding, corporate communications, corporate
affairs, marketing, public relations and investor relations
departments. Speakers will also include doctors, cross industry
speakers and analysts. |
